Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
Identifieur interne : 000709 ( PubMed/Checkpoint ); précédent : 000708; suivant : 000710Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
Auteurs : Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.
English descriptors
- KwdEn :
- Aged, Akathisia, Drug-Induced (physiopathology), Antiparkinson Agents (therapeutic use), Brain Diseases (etiology), Delusions (chemically induced), Depressive Disorder, Major (complications), Depressive Disorder, Major (drug therapy), Drug Interactions, Drug Therapy, Combination, Female, Humans, Indans (adverse effects), Indans (therapeutic use), Myoclonus (chemically induced), Myoclonus (physiopathology), Neuroprotective Agents (adverse effects), Neuroprotective Agents (therapeutic use), Parkinson Disease (complications), Parkinson Disease (drug therapy), Serotonin Syndrome (etiology), Serotonin Syndrome (physiopathology), Serotonin Uptake Inhibitors (adverse effects), Serotonin Uptake Inhibitors (therapeutic use), Sertraline (adverse effects), Sertraline (therapeutic use).
- MESH :
- chemical , adverse effects : Indans, Neuroprotective Agents, Serotonin Uptake Inhibitors, Sertraline.
- chemical , therapeutic use : Antiparkinson Agents, Indans, Neuroprotective Agents, Serotonin Uptake Inhibitors, Sertraline.
- chemically induced : Delusions, Myoclonus.
- complications : Depressive Disorder, Major, Parkinson Disease.
- drug therapy : Depressive Disorder, Major, Parkinson Disease.
- etiology : Brain Diseases, Serotonin Syndrome.
- physiopathology : Akathisia, Drug-Induced, Myoclonus, Serotonin Syndrome.
- Aged, Drug Interactions, Drug Therapy, Combination, Female, Humans.
DOI: 10.1002/mds.25416
PubMed: 23495033
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23495033Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</title><author><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name><affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, CHU Bordeaux, Pessac</wicri:regionArea><wicri:noRegion>Pessac</wicri:noRegion><wicri:noRegion>Pessac</wicri:noRegion></affiliation></author><author><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name></author><author><name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name></author><author><name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23495033</idno><idno type="pmid">23495033</idno><idno type="doi">10.1002/mds.25416</idno><idno type="wicri:Area/PubMed/Corpus">000700</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000700</idno><idno type="wicri:Area/PubMed/Curation">000669</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000669</idno><idno type="wicri:Area/PubMed/Checkpoint">000669</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000669</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</title><author><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name><affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, CHU Bordeaux, Pessac</wicri:regionArea><wicri:noRegion>Pessac</wicri:noRegion><wicri:noRegion>Pessac</wicri:noRegion></affiliation></author><author><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name></author><author><name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name></author><author><name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Akathisia, Drug-Induced (physiopathology)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Brain Diseases (etiology)</term><term>Delusions (chemically induced)</term><term>Depressive Disorder, Major (complications)</term><term>Depressive Disorder, Major (drug therapy)</term><term>Drug Interactions</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Indans (adverse effects)</term><term>Indans (therapeutic use)</term><term>Myoclonus (chemically induced)</term><term>Myoclonus (physiopathology)</term><term>Neuroprotective Agents (adverse effects)</term><term>Neuroprotective Agents (therapeutic use)</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Serotonin Syndrome (etiology)</term><term>Serotonin Syndrome (physiopathology)</term><term>Serotonin Uptake Inhibitors (adverse effects)</term><term>Serotonin Uptake Inhibitors (therapeutic use)</term><term>Sertraline (adverse effects)</term><term>Sertraline (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Indans</term><term>Neuroprotective Agents</term><term>Serotonin Uptake Inhibitors</term><term>Sertraline</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Indans</term><term>Neuroprotective Agents</term><term>Serotonin Uptake Inhibitors</term><term>Sertraline</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Delusions</term><term>Myoclonus</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Depressive Disorder, Major</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder, Major</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Brain Diseases</term><term>Serotonin Syndrome</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Akathisia, Drug-Induced</term><term>Myoclonus</term><term>Serotonin Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Drug Interactions</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23495033</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>30</Day></DateCreated><DateCompleted><Year>2014</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2013</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>10</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</ArticleTitle><Pagination><MedlinePgn>1464</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25416</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duval</LastName><ForeName>Fanny</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flabeau</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Razafimahefa</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Spampinato</LastName><ForeName>Umberto</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Tison</LastName><ForeName>François</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007189">Indans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>003N66TS6T</RegistryNumber><NameOfSubstance UI="C031967">rasagiline</NameOfSubstance></Chemical><Chemical><RegistryNumber>QUC7NX6WMB</RegistryNumber><NameOfSubstance UI="D020280">Sertraline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017109" MajorTopicYN="N">Akathisia, Drug-Induced</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003702" MajorTopicYN="N">Delusions</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007189" MajorTopicYN="N">Indans</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009207" MajorTopicYN="N">Myoclonus</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020230" MajorTopicYN="N">Serotonin Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017367" MajorTopicYN="N">Serotonin Uptake Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020280" MajorTopicYN="N">Sertraline</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23495033</ArticleId><ArticleId IdType="doi">10.1002/mds.25416</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country></list><tree><noCountry><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name><name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name><name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name></noCountry><country name="France"><noRegion><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000709 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000709 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23495033
|texte= Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23495033" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |